Mianserin Remedica (Mianserin Hydrochloride)

Mianserin is indicated for conditions within the depressive disorder spectrum.

• Major depressive disorder: reduces depressive symptoms and improves overall mood.
• Treatment‑resistant depression: may be added when first‑line agents are insufficient.
• Adjunctive therapy for anxiety associated with depression: helps alleviate concurrent anxiety symptoms.

• Mianserin acts primarily as an antagonist of central presynaptic α2‑adrenergic receptors, which increases norepinephrine release. It also blocks several serotonin receptors (5‑HT2 and 5‑HT3), enhancing serotonergic neurotransmission. The combined effect leads to heightened monoaminergic activity that contributes to its antidepressant properties.

Mianserin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Drowsiness: feeling unusually sleepy or fatigued.
• Dry mouth: reduced salivation leading to a parched sensation.
• Weight gain: increase in body weight over time.
• Constipation: difficulty passing stools.
• Dizziness: sensation of light‑headedness or unsteadiness.
• Increased appetite: heightened desire for food.

Serious or Rare Side Effects

• Agranulocytosis: severe reduction in white blood cells.
• Seizures: convulsive episodes, especially at high doses.
• Severe hypotension: marked drop in blood pressure causing faintness.
• Cardiac arrhythmia: irregular heart rhythm that may be life‑threatening.
• Suicidal ideation: emergence or worsening of thoughts of self‑harm.
• Blood dyscrasias: abnormal blood cell counts or function.

Before prescribing Mianserin, clinicians should consider several safety factors.

• Monitor mood: watch for worsening depression or emergence of suicidal thoughts.
• Avoid abrupt discontinuation: taper the dose to reduce withdrawal symptoms.
• Use caution in the elderly: increased sensitivity to sedation and orthostatic hypotension.
• Assess hepatic function: dose adjustment may be needed in liver impairment.
• Evaluate cardiovascular status: patients with pre‑existing heart disease require close observation.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Mianserin can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis and serotonin syndrome.
• Selective serotonin reuptake inhibitors (SSRIs) or other serotonergic agents: increased risk of serotonin syndrome.
• CNS depressants (e.g., benzodiazepines, barbiturates): additive sedation and respiratory depression.

Moderate Interactions (Monitor Closely):\n- Alcohol: may enhance drowsiness and impair coordination.

• Anticholinergic drugs: can exacerbate dry mouth and constipation.
• CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may raise Mianserin plasma levels.
• Antihistamines: potential increase in sedation.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of gastrointestinal bleeding.